Skip to main content

Advertisement

SpringerLink
Log in

Update on diagnosis and management of chronic pancreatitis

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Chronic pancreatitis should be considered in all patients with unexplained abdominal pain. The importance of small duct disease without obvious radiographic abnormalities is an important new concept. It is meaningful for the clinician to define whether the patient with chronic pancreatitis has small duct or large duct disease. Diagnostic evaluations should begin with a simple, noninvasive, inexpensive test such as serum trypsinogen, to be followed by more complicated testing such as the secretin stimulation test, particularly in those patients with small duct disease. Non-enteric-coated pancreatic enzyme preparations are preferred for the treatment of pain whereas enteric-coated pancreatic enzyme preparations are the drugs of choice for treating steatorrhea. Octreotide may become an important therapy for treating abdominal pain unresponsive to pancreatic enzyme therapy. Endoscopic treatment of the pain of chronic pancreatitis should be used only in highly selected patients and may cause damage to the pancreas. Surgical ductal decompression is appropriate in selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Toskes PP, Greenberger NJ: Approach to the patient with pancreatic disease. In Harrison’s Principles of Internal Medicine, edn 14. Edited by Fauci AS, Braunwald E, Isselbacher, KJ, Martin, JB. New York: McGraw Hill; 1998:1737–1741.

    Google Scholar 

  2. Greenberger NJ, Toskes PP, Isselbacher K: Diseases of the pancreas. In Harrison’s Principles of Internal Medicine edn 14. Edited by Fauci AS, Braunwald E, Isselbacher, KJ, Martin, JB. New York: McGraw Hill; 1998:1741–1752.

    Google Scholar 

  3. Go VLW, Everhart JE: Pancreatitis. In Digestive Diseases in the United States: Epidemiology and Impact. Edited by Everhart JE. National Institutes of Health Publication 94-1447. Washington DC: US Government Printing Office; 1994:691–712.

    Google Scholar 

  4. Walsh TN, Rode J, Theis BA, Russell RCG: Minimal change chronic pancreatitis. Gut 1992, 33:1566–1571.

    Article  PubMed  CAS  Google Scholar 

  5. Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141–145.

    Article  PubMed  CAS  Google Scholar 

  6. Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653–658. Points out that idiopathic chronic pancreatitis may be a result of genetic defects.

    Article  PubMed  CAS  Google Scholar 

  7. Toskes PP: Medical management of chronic pancreatitis. Scand J Gastroenterol 1995, 30(Suppl 208):74–80.

    Article  Google Scholar 

  8. Freiss H, Yamanaka Y, Buchler M, et al.: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994, 144:117–128.

    Google Scholar 

  9. Korc M, Freiss H, Yamanaka Y, et al.: Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor, and phospholipase. Gut 1994, 35:1468–1473.

    Article  PubMed  CAS  Google Scholar 

  10. Chey, WY: Neurohormonal control of the exocrine pancrease. Curr Opin Gastroenterol 1997;13:375–380. A helpful review of feedback mechanisms controlling pancreatic exocrine secretion.

    Article  CAS  Google Scholar 

  11. Hayakawa T, Kondo T, Shibata T, et al: Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol 1992; 87:1170–1174. Reports on a pivotal study providing the histological"gold standard" for the secretin test.

    PubMed  CAS  Google Scholar 

  12. Forsmark CE, Toskes PP: What does an abnormal pancreatogram mean? Gastrointest Endosc Clin North Am 1995, 5:105–123. A critical reappraisal of ERP in the diagnosis of chronic pancreatitis.

    CAS  Google Scholar 

  13. Cobson DG, Curington C, Connery K, et al.: Trypsin-like immunoreactivity as a test for pancreatic insufficiency. N Engl J Med 1984, 310:1307–1309.

    Article  Google Scholar 

  14. Toskes PP, Greenberger NJ: Acute and chronic pancreatitis. Dis Mon 1983, 29:1–81.

    PubMed  CAS  Google Scholar 

  15. Ochi K, Harada H, Mizushima T, Tanaka J, Matsumoto S: Intraductal secretion test is as useful as duodenal secretin test in assessing exocrine pancreatic function. Dig Dis Sci 1997, 42:492–496.

    Article  PubMed  CAS  Google Scholar 

  16. Ammann RW, Muelhaupt B: Progression of alcoholic acute to chronic pancreatitis. Gut 1994, 35:552–556.

    Article  PubMed  CAS  Google Scholar 

  17. Ammann RW, Muelhaupt B, Meyenberger C, et al.: Alcoholic nonprogressive chronic pancreatitis: Prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976–1992). Pancreas 1994, 9:365–373.

    Article  PubMed  CAS  Google Scholar 

  18. Smyth RL, Van Velzen D, Smyth AR, et al.: Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994, 343:85–86.

    Article  PubMed  CAS  Google Scholar 

  19. Strum WB: Abstinence in alcoholic chronic pancreatitis; Effect on pain and outcome. J Clin Gastroenterol 1995, 20:37–41.

    Article  PubMed  CAS  Google Scholar 

  20. Slaff JI, Wolfe M. Toskes PP: Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: Evidence to support feedback regulation. J Lab Clin Med 1985, 105:282–285.

    PubMed  CAS  Google Scholar 

  21. Funakoshi A, Nakano I, Shinozaki H, et al.: High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Am J Gastroenterol 1986, 81:1174–1178.

    PubMed  CAS  Google Scholar 

  22. Isaksson G, Ihse I: Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983, 28:97–102.

    Article  PubMed  CAS  Google Scholar 

  23. Slaff J, Jacobson D, Tillman CR, et al.: Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984, 87:44–52.

    PubMed  CAS  Google Scholar 

  24. Malesci A, Gaia E, Fioretta A, et al.: No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis. Scand J Gastroenterol 1995, 30:392–398.

    Article  PubMed  CAS  Google Scholar 

  25. Halgreen H, Pederson NT, Worning H: Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 1986, 21:104–108.

    Article  PubMed  CAS  Google Scholar 

  26. Mossner J, Secknus R, Meyer J, et al.: Treatment of pain with pancreatic extracts in chronic pancreatitis: Results of a prospective placebo-controlled multi-center trial. Digestion 1992, 53:54–66.

    Article  PubMed  CAS  Google Scholar 

  27. Larvin M, McMahon MJ, Thomas WEG, et al.: Creon (entericcoated Pancreatic microspheres) for the treatment of pain in chronic pancreatitis: A double-blind, randomized, placebocontrolled, crossover study [abstract]. Gastroenterology 1991:100:A283.

    Google Scholar 

  28. Brown A, Hughes M, Tenner S, et al.: Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: A meta-analysis. Am J Gastroenterol 1997, 92:2032–2035.

    PubMed  CAS  Google Scholar 

  29. Toskes PP, Forsmark CE, DeMeo MT, et al.: A multi-center controlled trial of octreotide for the pain of chronic pancreatitis. Pancreas 1999, in press. Report on a placebo-controlled, double-blind, dose-ranging study of octreotide in treating pain of chronic pancreatitis.

  30. Burdick JS, Geenen JE, Hogan WJ, et al.: Pancreatic stent therapy in chronic pancreatitis: which patients benefit [abstract]. Gastrointest Endosc 1993, 39:309A.

    Article  Google Scholar 

  31. Lehman GA, Sherman S, Nisi R, et al.: Pancreas divisum: Results of minor papilla sphincterotomy. Gastrointest Endosc 1993, 39:1–8. Placebo-controlled, double-blind, dose-ranging pilot study of octreotide in treating pain of chronic pancreatitis.

    Article  PubMed  CAS  Google Scholar 

  32. Adams DB, Ford MC, Anderson MD: Outcome after lateral pancreaticojejunostomy for chronic pancreatitis. Ann Surg 1994, 219:481–489.

    Article  PubMed  CAS  Google Scholar 

  33. Lembecke B, Kraus B, Lankisch PG: Small intestinal function in chronic relapsing pancreatitis. Hepatogastroenterology 1985, 32:149–151.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Florida College of Medicine, JHMHC, Box 100277, 32610, Gainesville, FL, USA

    Phillip P. Toskes MD

Authors
  1. Phillip P. Toskes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toskes, P.P. Update on diagnosis and management of chronic pancreatitis. Curr Gastroenterol Rep 1, 145–153 (1999). https://doi.org/10.1007/s11894-996-0014-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-996-0014-8

Keywords

Search

Navigation